Dynorphin immunoreactive fibers contact GnRH neurons in the human hypothalamus

Reproductive Sciences

Volumn 16, Issue 8, 2009, Pages 781-787

  Dahl, Stephanie K ^a,b   Amstalden, Marcel ^a   Coolen, Lique ^a   Fitzgerald, Maureen ^a   Lehman, Michael ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Close contacts; Dynorphin; Endogenous opioid peptides; GnRH neurons

Indexed keywords

DYNORPHIN; GONADORELIN;

ADULT; ARTICLE; CONTROLLED STUDY; DENDRITE; FEMALE; HORMONE PROTEIN COMPLEX; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; NERVE FIBER; NEUROANATOMY; PREOPTIC AREA; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; DENDRITES; DYNORPHINS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NERVE FIBERS; NEURAL PATHWAYS; NEURONS;

EID: 67650462851     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719109336619     Document Type: Article

References (26)

1. Fritz MA, Speroff L. The endocrinology of the menstrual cycle: the interactions of folliculogenesis and neuroendocrine mechanisms. Fertil Steril. 1982 ; 38 (5). 509-529.
2. Brann DW, Mahesh VB Regulation of gonadotropin secretion by steroid hormones. Front Neuroendocrinol. 1991 ; 12 (2). 165-207.
3. Skinner DC, Evans NP, Delaleu B., Goodman RL, Bouchard P., Caraty A. The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor. Proc Natl Acad Sci. 1998 ; 95 (18). 10978-10983. (Pubitemid 28413179)
4. Skinner DC, Caraty A., Allingham R. Unmasking the progesterone receptor in the preoptic area and hypothalamus of the ewe: no colocalization with gonadotropin-releasing neurons. Endocrinology. 2001 ; 142 (2). 573-579. (Pubitemid 32222405)
5. Foradori CD, Coolen LM, Fitzgerald ME, Skinner DC, Goodman RL, Lehman MN Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. Endocrinology. 2002 ; 143 (11). 4366-4374. (Pubitemid 35239570)
6. Goodman RL, Coolen LM, Anderson GM, et al. Evidence that dynorphin plays a major role in mediating progesterone negative feedback on gonadotropin- releasing hormone neurons in sheep. Endocrinology. 2004 ; 145 (6). 2959-2967. (Pubitemid 38686245)
7. Ferin M. Endogenous opioid peptides and the menstrual cycle. Trends Neurosci. 1984 ; 7 (6). 194-196. (Pubitemid 14122417)
8. Moore MR, Black PM Neuropeptides. Neurosurg Rev. 1991 ; 14 (2). 97-110.
9. Foradori CD, Goodman RL, Adams VL, Valent M., Lehman MN Progesterone increases dynorphin a concentrations in cerebrospinal fluid and preprodynorphin messenger ribonucleic acid levels in a subset of dynorphin neurons in the sheep. Endocrinology. 2005 ; 146 (4). 1835-1842. (Pubitemid 40396893)
10. Tan-No K., Takahashi H., Nakagawasai O., et al. Pronociceptive role of dynorphins in uninjured animals:N-ethylmaleimideinduced nociceptive behavior mediated through inhibition of dynorphin degradation. Pain. 2005 ; 113 (3). 301-309. (Pubitemid 40127511)
11. Dudas B., Merchenthaler I. Close anatomical associations between b-endorphin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon. Neuroscience. 2004 ; 124 (1). 221-229. (Pubitemid 38186631)
12. Abe J., Okamura H., Kitamura T., et al. Immunocytochemical demonstration of dynorphin (PH-8P)-like immunoreactive elements in the human hypothalamus. J Comp Neurol. 1988 ; 276 (4). 508-513. (Pubitemid 18252686)
13. Dudas B., Merchenthaler I. Topography and Associations of Leu-Enkephalin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon. J Clin Endocrinol Metab. 2003 ; 88 (4). 1842-1848. (Pubitemid 36623413)
14. Watson RE Jr, Hoffmann GE, Wiegand SJ Sexually dimorphic opioid distribution in the preoptic area: manipulation by gonadal steroids. Brain Res. 1986 ; 398 (1). 157-163. (Pubitemid 17184893)
15. Simerly RB, McCall LD, Watson SJ Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism. J Comp Neurol. 1988 ; 276 (3). 442-459. (Pubitemid 18262080)
16. Steele PA, Judd SJ Role of endogenous opioids in reducing the frequency of pulsatile luteinizing hormone secretion induced by progesterone in normal women. Clin Endocrin. 1986 ; 25 (6). 669-674. (Pubitemid 17187546)
17. Ropert JF, Quigley ME, Yen SSC. Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab. 1981 ; 52 (3). 583-585. (Pubitemid 11136579)
18. Quigley ME, Yen SSC. Role of endogenous opiates on LH secretion during the menstrual cycle. J Clin Endocrinol Metabol. 1980 ; 51 (1). 179-181. (Pubitemid 10009262)
19. Casper RF, Alapin-Rubillovitz S. Progestins increase endogenous opioid peptide activity in postmenopausal women. J Clin Endocrinol Metabol. 1985 ; 60 (1). 34-36. (Pubitemid 15194643)
20. Shoupe D., Montz FJ, Lobo RA The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab. 1985 ; 60 (1). 178-183. (Pubitemid 15194668)
21. Chavkin C., James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science. 1982 ; 215 (4531). 413-415.
22. Kalra SP, Kalra PS Opioid-adrenergic-steroid connection in regulation of luteinizing hormone secretion in the rat. Neuroendocrinology. 1984 ; 38 (5). 418-426. (Pubitemid 14135597)
23. Aleem FA, McIntash T. Elevated plasma levels of b-endorphin in a group of women with polycystic ovarian disease. Fertil Steril. 1984 ; 42 (5). 686-689. (Pubitemid 15202319)
24. Wildt L., Leyendecker G., Sir-Petermann T., Waibel-Treber S. Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Hum Reprod. 1993 ; 8 (3). 350-358. (Pubitemid 23106807)
25. Whisnant CS, Havern RL, Goodman RL Endogenous opioid suppression of luteinizing hormone pulse frequency and amplitude in the ewe: hypothalamic sites of action. Neuroendocrinology. 1991 ; 54 (6). 587-593.
26. Lung FD, Chen CH, Liu JH Development of highly potent and selective dynorphin a analogues as new medicines. J Pept Res. 2005 ; 66 (5). 263-276.